XML 58 R35.htm IDEA: XBRL DOCUMENT v3.24.2
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
The components of the Company’s share-based compensation expense for the six months ended June 30, 2024 and 2023 are as follows:
Six Months Ended June 30,
20242023
(in thousands)
Stock options$353 $463 
Restricted stock, restricted stock units and deferred stock units3,501 3,223 
Performance stock units665 565 
Employee Stock Purchase Plan78 158 
Total pre-tax share-based compensation expense charged against income$4,597 $4,409 

The following table summarizes the components of share-based compensation expense included within the Consolidated Statements of Comprehensive (Loss) Income for the six months ended June 30, 2024 and 2023:

Six Months Ended June 30,
20242023
(in thousands)
Selling, general and administrative expense$4,572 $4,363 
Costs of services provided25 46 
Total share-based compensation expense$4,597 $4,409 
Schedule of Stock Options Outstanding
A summary of stock options outstanding under the Amended 2020 Plan and the 2012 Plan as of December 31, 2023 and changes during the six months ended June 30, 2024 are as follows:
Stock Options Outstanding
Number of SharesWeighted Average Exercise Price
(in thousands)
December 31, 20232,438 $30.43 
Granted290 $10.36 
Exercised— $— 
Forfeited(1)$24.43 
Expired(179)$28.45 
June 30, 20242,548 $28.29 
Schedule of Assumption for Fair Value of Options Granted
The fair value of stock option awards granted during the six months ended June 30, 2024 and 2023 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:
Six Months Ended June 30,
20242023
Risk-free interest rate3.9 %4.0 %
Weighted average expected life7.0 years6.9 years
Expected volatility40.5 %39.5 %
Dividend yield— %— %
Schedule of Other Information about Stock Options
The following table summarizes other information about the stock options at June 30, 2024:
June 30, 2024
(amounts in thousands, except per share data)
Outstanding:
Aggregate intrinsic value$64 
Weighted average remaining contractual life4.9 years
Exercisable:
Number of options1,756 
Weighted average exercise price$33.93 
Aggregate intrinsic value$— 
Weighted average remaining contractual life3.4 years
Schedule of Outstanding Restricted Stock Units
A summary of the outstanding restricted stock units as of December 31, 2023 and changes during the six months ended June 30, 2024 is as follows:
Restricted Stock Units
NumberWeighted Average Grant Date Fair Value
(in thousands)
December 31, 20231,102 $18.57 
Granted770 $10.38 
Vested(297)$21.68 
Forfeited(17)$14.17 
June 30, 20241,558 $13.97 
Schedule of Outstanding Performance Stock Units
A summary of the outstanding PSUs as of December 31, 2023 and changes during the six months ended June 30, 2024 is as follows:

Performance Stock Units
NumberWeighted Average Grant Date Fair Value
(in thousands)
December 31, 2023175 $21.52 
Granted118 $11.85 
Vested— $— 
Forfeited(35)$34.52 
June 30, 2024258 $15.31 
Schedule of Options Granted Under Employee Stock Purchase Plan
The expense associated with the options granted under the ESPP during the six months ended June 30, 2024 and 2023 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:
Six Months Ended June 30,
20242023
Risk-free interest rate4.8%4.8%
Weighted average expected life (years)1.01.0
Expected volatility37.1%42.9%
Dividend yield—%7.1%
Schedule of Supplemental Employee Retirement Plan
The following table summarizes information about the SERP during the six months ended June 30, 2024 and 2023:
Six Months Ended June 30,
 20242023
(in thousands)
SERP expense 1
$355 $298 
Unrealized gain recorded in SERP liability account$5,350 $3,871 
1.Both the SERP match and the deferrals are included in the Selling, general and administrative expense caption within the Consolidated Statements of Comprehensive (Loss) Income.